Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 06, 2021

SELL
$33.06 - $56.93 $680,044 - $1.17 Million
-20,570 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$39.09 - $57.4 $804,081 - $1.18 Million
20,570 New
20,570 $860,000
Q3 2020

Nov 13, 2020

SELL
$28.43 - $44.67 $654,003 - $1.03 Million
-23,004 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$11.71 - $30.29 $269,376 - $696,791
23,004 New
23,004 $697,000

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Blueshift Asset Management, LLC Portfolio

Follow Blueshift Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blueshift Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Blueshift Asset Management, LLC with notifications on news.